Optimi Health Receives Finished Product Test Results and Certificate Of Analysis for GMP Natural Psilocybin Extract
02 avr. 2024 07h30 HE
|
Optimi Health Corp.
Optimi receives Certificate Of Analysis for GMP Natural Psilocybin Extract. Company has also completed the in-house encapsulation of 5mg & 10mg psilocybin.
PharmAla Biotech Signs Sale Agreement with Numinus
26 mars 2024 08h55 HE
|
PharmAla Biotech
PharmAla announces binding sales order from Numinus Wellness, as well as a recent presentation of data to the Behaviour, Biology, and Chemistry Conference
CARBOGEN AMCIS announces successful ANVISA audit of its facility in China
19 mars 2024 13h58 HE
|
CARBOGEN AMCIS INNOVATIONS AG
CARBOGEN AMCIS announces successful completion of its first Brazilian Regulatory Authority Agency (ANVISA) routine inspection of its Shanghai facility
Cortexa Leads the World in First Supply of Psilocybin Under the TGA’s Authorized Prescriber Scheme
18 mars 2024 08h55 HE
|
PharmAla Biotech
PharmAla's 50:50 Joint Venture with Vitura Health Limited, Cortexa, announces it is first entity to supply Psilocybin into Authorized Prescriber Scheme
Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment - Issues and Solutions Training Course
14 mars 2024 13h54 HE
|
Research and Markets
Dublin, March 14, 2024 (GLOBE NEWSWIRE) -- The "Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment - Issues and Solutions Training Course" training has been added to ...
Vantage Hemp Co. Achieves GMP Certification from Australia's Therapeutic Goods Administration
29 févr. 2024 07h00 HE
|
Vantage Hemp Co.
Greeley, Colorado, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Vantage Hemp Co. (“Vantage” or “the Company”), a globally accredited plant-based extractor and finished product manufacturer, is proud to...
AgriFORCE Granted Further Patent from the USPTO Related to its FORCEGH+ Facilities
16 févr. 2024 17h00 HE
|
AgriFORCE Growing Systems Ltd.
VANCOUVER, British Columbia, Feb. 16, 2024 (GLOBE NEWSWIRE) -- AgriFORCE Growing Systems Ltd. (“the Company”) (NASDAQ: AGRI; AGRIW), an intellectual property (IP) focused AgTech company, today...
Optimi Health Congratulates Lykos Therapeutics on FDA Priority Review of New Drug Application And Releases MDMA Production Video
12 févr. 2024 07h00 HE
|
Optimi Health Corp.
Optimi Health Congratulates Lykos Therapeutics on FDA Priority Review of New Drug Application And Releases MDMA Production Video
Quality Control Laboratory Compliance - 2 Day Virtual cGMP and GLP Training
09 févr. 2024 07h43 HE
|
Research and Markets
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The "Quality Control Laboratory Compliance - cGMP and GLP Training" has been added to ResearchAndMarkets.com's offering.Ensuring compliance with FDA...
Optimi Health To Host MDMA Educational Quality Assurance Webinar For Clinicians And Practitioners
06 févr. 2024 07h30 HE
|
Optimi Health Corp.
Highlights: Optimi Chief Science and Quality Assurance experts to provide in-depth access into the Company’s safety and quality standards.Optimi experts will address critical inquiries which still...